Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,078
archived clinical trials in
Major Depression Disorder (MDD)

Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative Site
mi
from
Cerritos, CA
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative Site
mi
from
Cerritos, CA
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative Site
mi
from
Denver, CO
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative Site
mi
from
Denver, CO
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative Site
mi
from
Brooksville, FL
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative Site
mi
from
Brooksville, FL
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative Site
mi
from
Owensboro, KY
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative Site
mi
from
Owensboro, KY
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative Site
mi
from
Atlanta, GA
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative Site
mi
from
Atlanta, GA
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative Site
mi
from
Oak Brook, IL
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative Site
mi
from
Oak Brook, IL
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative Site
mi
from
Las Vegas, NV
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative Site
mi
from
Las Vegas, NV
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative site
mi
from
Cherry Hill, NJ
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative site
mi
from
Cherry Hill, NJ
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative Site
mi
from
Albuquerque, NM
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative Site
mi
from
Albuquerque, NM
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative Site
mi
from
Fresh Meadows, NY
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative Site
mi
from
Fresh Meadows, NY
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative Site
mi
from
Cincinnati, OH
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative Site
mi
from
Cincinnati, OH
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative Site
mi
from
Oklahoma City, OK
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative Site
mi
from
Oklahoma City, OK
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative site
mi
from
Allentown, PA
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative site
mi
from
Allentown, PA
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative Site
mi
from
Anderson, SC
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative Site
mi
from
Anderson, SC
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative Site
mi
from
Memphis, TN
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative Site
mi
from
Memphis, TN
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative Site
mi
from
Austin, TX
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative Site
mi
from
Austin, TX
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative Sites
mi
from
Lake Jackson, TX
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative Sites
mi
from
Lake Jackson, TX
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative Site
mi
from
Orem, UT
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative Site
mi
from
Orem, UT
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative Site
mi
from
Richmond, VA
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative Site
mi
from
Richmond, VA
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Rexahn Investigative Site
mi
from
Bellevue, WA
Safety and Efficacy of RX-10100 to Treat Major Depressive Disorder
A Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study of RX-10100 in Subjects With Major Depressive Disorder.
Status: Archived
Updated: 1/1/1970
Rexahn Investigative Site
mi
from
Bellevue, WA
Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study
Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study
Status: Archived
University of North Carolina Hospital at Chapel Hill
mi
from
Chapel Hill, NC
Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study
Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study
Status: Archived
Updated: 1/1/1970
University of North Carolina Hospital at Chapel Hill
mi
from
Chapel Hill, NC
Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder
A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Major Depression Disorder (MDD)
Status: Archived
David Geffen School of Medicine, UCLA
mi
from
Los Angeles, CA
Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder
A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Major Depression Disorder (MDD)
Status: Archived
Updated: 1/1/1970
David Geffen School of Medicine, UCLA
mi
from
Los Angeles, CA
Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder
A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Major Depression Disorder (MDD)
Status: Archived
University of California, San Francisco, Fresno, School of Medicine
mi
from
Fresno, CA
Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder
A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Major Depression Disorder (MDD)
Status: Archived
Updated: 1/1/1970
University of California, San Francisco, Fresno, School of Medicine
mi
from
Fresno, CA
Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder
A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Major Depression Disorder (MDD)
Status: Archived
Advanced Mental Health Care Inc. - Juno Beach
mi
from
Juno Beach, FL
Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder
A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Major Depression Disorder (MDD)
Status: Archived
Updated: 1/1/1970
Advanced Mental Health Care Inc. - Juno Beach
mi
from
Juno Beach, FL
Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder
A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Major Depression Disorder (MDD)
Status: Archived
Advanced Mental Health Care Inc. - Royal Palm Beach
mi
from
Royal Palm Beach, FL
Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder
A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Major Depression Disorder (MDD)
Status: Archived
Updated: 1/1/1970
Advanced Mental Health Care Inc. - Royal Palm Beach
mi
from
Royal Palm Beach, FL
Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder
A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Major Depression Disorder (MDD)
Status: Archived
Johns Hopkins University
mi
from
Baltimore, MD
Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder
A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Major Depression Disorder (MDD)
Status: Archived
Updated: 1/1/1970
Johns Hopkins University
mi
from
Baltimore, MD
Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder
A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Major Depression Disorder (MDD)
Status: Archived
McLean Hospital
mi
from
Belmont, MA
Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder
A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Major Depression Disorder (MDD)
Status: Archived
Updated: 1/1/1970
McLean Hospital
mi
from
Belmont, MA
Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder
A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Major Depression Disorder (MDD)
Status: Archived
Columbia Presbyterian Med Ctr
mi
from
New York, NY
Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder
A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Major Depression Disorder (MDD)
Status: Archived
Updated: 1/1/1970
Columbia Presbyterian Med Ctr
mi
from
New York, NY
Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder
A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Major Depression Disorder (MDD)
Status: Archived
Medical University of South Carolina
mi
from
Charleston, SC
Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder
A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Major Depression Disorder (MDD)
Status: Archived
Updated: 1/1/1970
Medical University of South Carolina
mi
from
Charleston, SC
Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder
A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Major Depression Disorder (MDD)
Status: Archived
UT Soutwestern Medical Center at Dallas
mi
from
Dallas, TX
Evaluation of the Brainsway Deep Transcranial Magnetic Stimulation (TMS) H-Coil in the Treatment of Major Depression Disorder
A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore the Tolerability, Safety and Efficacy of the H-Coil Deep Transcranial Magnetic Stimulation (TMS) in Subjects With Major Depression Disorder (MDD)
Status: Archived
Updated: 1/1/1970
UT Soutwestern Medical Center at Dallas
mi
from
Dallas, TX
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Lincoln Medical Center
mi
from
Lincoln, NE
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Lincoln Medical Center
mi
from
Lincoln, NE
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site
mi
from
Sacramento, CA
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Sacramento, CA
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site
mi
from
Denver, CO
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Denver, CO
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site
mi
from
Cromwell, CT
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Cromwell, CT
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site
mi
from
Boca Raton, FL
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Boca Raton, FL
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site
mi
from
Chicago, IL
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Chicago, IL
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site
mi
from
Wichita, KA
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Wichita, KA
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site
mi
from
Baltimore, MD
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Baltimore, MD
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Sheppard Pratt Health System
mi
from
Baltimore, MD
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Sheppard Pratt Health System
mi
from
Baltimore, MD
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site
mi
from
Manhasset, NY
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Manhasset, NY
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site
mi
from
Raleigh, NC
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Raleigh, NC
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site
mi
from
Cleveland, OH
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Cleveland, OH
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site
mi
from
Portland, OR
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Portland, OR
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site
mi
from
Pittsburgh, PA
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Pittsburgh, PA
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site
mi
from
Lincoln, RI
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Lincoln, RI
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site
mi
from
Memphis, TN
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Memphis, TN
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site
mi
from
Dallas, TX
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Dallas, TX
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Forest Investigative Site
mi
from
Bellevue, WA
Safety and Efficacy of F2695 SR in Major Depressive Disorder
A Double-blind, Placebo-Controlled, Fixed-Dose Study of F2695 SR in Patients With Major Depressive Disorder
Status: Archived
Updated: 1/1/1970
Forest Investigative Site
mi
from
Bellevue, WA
Brain Imaging of Quetiapine Response in Anxious Depression
Brain Imaging of Quetiapine Response in Anxious Depression
Status: Archived
Indiana University Adult Psychiatry Clinic
mi
from
Indianapolis, IN
Brain Imaging of Quetiapine Response in Anxious Depression
Brain Imaging of Quetiapine Response in Anxious Depression
Status: Archived
Updated: 1/1/1970
Indiana University Adult Psychiatry Clinic
mi
from
Indianapolis, IN
rTMS for Adolescents and Young Adults
rTMS for Adolescent and Young Adult Depression
Status: Archived
Johns Hopkins Hosp
mi
from
Baltimore, MD
rTMS for Adolescents and Young Adults
rTMS for Adolescent and Young Adult Depression
Status: Archived
Updated: 1/1/1970
Johns Hopkins Hosp
mi
from
Baltimore, MD